Agno Pharma
Lianyungang, Jiangsu, China
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: Agno Pharma
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Lianyungang, Jiangsu, China
- Website
- https://www.agnopharma.com/
- Modalities
- Small Molecule API, Intermediates, Sterile Injectables, Clinical Trial Manufacturing
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Agno Pharma
Agno Pharma is a contract development and manufacturing organization (CDMO). Capabilities: Small Molecule API, Intermediates, Sterile Injectables, Clinical Trial Manufacturing. 2 manufacturing sites registered with the U.S. FDA. Website: https://www.agnopharma.com/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Agno Pharma FDA Inspection History
2024-06
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2024-06-07 |
Agno Pharma Jiangsu
Lianyungang
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Frequently Asked Questions About Agno Pharma
How many FDA inspections does Agno Pharma have on record?
CDMO Signal tracks 1 FDA inspection for Agno Pharma, sourced from the FDA inspection database. See the full inspection history above.
Has Agno Pharma received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Agno Pharma.
Does Agno Pharma have a CDMO Signal Score?
Not yet. Agno Pharma is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Agno Pharma for a manufacturing program?
Use the free AI matchmaker to compare Agno Pharma against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Viwit Pharmaceutical
Zaozhuang, Shandong, China
Small Molecule API, Intermediates, Oral Solid Dose, Sterile Injectables
Katayama Seiyakusyo
Hirakata, Osaka, Japan
Small Molecule API, Intermediates, Clinical Trial Manufacturing, Oral Solid Dose
Symeres
Nijmegen, Netherlands
Small Molecule API, Clinical Trial Manufacturing, Intermediates, Spray Drying
UBE Corporation (pharmaceutical contract manufacturing)
Ube, Yamaguchi, Japan
Small Molecule API, Intermediates, High-Potency APIs, Clinical Trial Manufacturing
Chiracon
Luckenwalde, Brandenburg, Germany
Small Molecule API, Intermediates, Clinical Trial Manufacturing
Compare Agno Pharma with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.